Noom Med gates tirzepatide medication pricing behind its eligibility questionnaire. We document what the company publicly lists—service fees, microdose intro rates, and program structure—and show where evidence ends.

PlexusDx publishes flat month-to-month GLP-1 rates; Noom Med splits service and medication costs across distinct programs. We compare the structures, where pricing overlaps, and what remains eligibility-gated.

Noom Med charges $129/month for its Core Med program after the first month, billed quarterly—but medication is priced separately. The microdose program has an introductory rate followed by a higher ongoing subscription cost.

Five microdose and low-dose tirzepatide telehealth programs compared on month-to-month cost, refill pricing, membership fees, and service quality. Evidence captured September 2026.